Characterization of biofilm-like structures formed by Pseudomonas aeruginosa in a synthetic mucus medium

BMC Microbiology

Volumn 12, Issue , 2012, Pages

  Haley, Cecily L ^a   Colmer Hamood, Jane A ^a   Hamood, Abdul N ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; MUCIN; OXYGEN;

ARTICLE; ARTIFICIAL SPUTUM MEDIUM; BACTERIAL STRAIN; BIOFILM; BIOFILM LIKE STRUCTURE; CYSTIC FIBROSIS; INOCULATION; MICROTITER PLATE ASSAY; MUCUS; NONHUMAN; OXYGEN CONCENTRATION; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; SPUTUM CULTURE; STAPHYLOCOCCUS AUREUS;

BACTERIAL ADHESION; BIOFILMS; CULTURE MEDIA; DNA, BACTERIAL; HUMANS; MUCINS; MUCUS; OXYGEN; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; STAPHYLOCOCCUS AUREUS;

PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 84865056405     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-12-181     Document Type: Article

References (65)

1. Pathophysiology and management of pulmonary infections in cystic fibrosis. Gibson RL, Burns JL, Ramsey BW, Am J Respir Crit Care Med 2003 168 918 951 10.1164/rccm.200304-505SO 14555458 (Pubitemid 37267172)
2. Identification of the cystic fibrosis gene: chromosome walking and jumping. Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N, Zsiga M, Buchwald M, Riordan JR, Tsue LC, Collins FS, Science 1989 245 1059 1065 10.1126/science.2772657 2772657 (Pubitemid 19231813)
3. Pseudomonas bacteremia. Baltch AL, Pseudomonas aeruginosa infection and treatment New York: Marcel Dekker, Smith RP, Baltch AL, 1994 73 128
4. Altered fluid transport across airway epithelium in cystic fibrosis. Jiang C, Finkbeiner WE, Widdicombe JH, McCray PB Jr, Miller SS, Science 1993 262 424 427 10.1126/science.8211164 8211164 (Pubitemid 23353385)
5. Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets. Hassett DJ, Cuppoletti J, Trapnell B, Lymar SV, Rowe JJ, Yoon SS, Hilliard GM, Parvatiyar K, Kamani MC, Wozniak DJ, Hwang SH, McDermott TR, Ochsner UA, Adv Drug Deliv Rev 2002 54 1425 1443 10.1016/S0169-409X(02)00152-7 12458153 (Pubitemid 35375769)
6. Clinical manifestations and treatment of pulmonary infections in cystic fibrosis. Burns JL, Ramsey BW, Smith AL, Adv Pediatr Infect Dis 1993 8 53 66 8217005
7. Pseudomonas aeruginosa. Pier GB, Ramphal R, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases Philadelphia: Churchill Livingstone, Mandell GL, Bennett JE, Dolin R, vol. 2, 7 2010 2835 2860
8. Lung infections associated with cystic fibrosis. Lyczak JB, Cannon CL, Pier GB, Clin Microbiol Rev 2002 15 194 222 10.1128/CMR.15.2.194-222.2002 11932230 (Pubitemid 34303763)
9. Biofilms: survival mechanisms of clinically relevant microorganisms. Donlan RM, Costerton JW, Clin Microbiol Rev 2002 15 167 193 10.1128/CMR.15.2. 167-193.2002 11932229 (Pubitemid 34303762)
10. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing. Leid JG, Willson CJ, Shirtliff ME, Hassett DJ, Parsek MR, Jeffers AK, J Immunol 2005 175 7512 7518 16301659 (Pubitemid 41713449)
11. Putative exopolysaccharide synthesis genes influence Pseudomonas aeruginosa biofilm development. Matsukawa M, Greenberg EP, J Bacteriol 2004 186 4449 4456 10.1128/JB.186.14.4449-4456.2004 15231776 (Pubitemid 38891007)
12. Antibiotic resistance of bacteria in biofilms. Stewart PS, Costerton JW, Lancet 2001 358 135 138 10.1016/S0140-6736(01)05321-1 11463434 (Pubitemid 32709857)
13. Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. Sauer K, Camper AK, Ehrlich GD, Costerton JW, Davies DG, J Bacteriol 2002 184 1140 1154 10.1128/jb.184.4.1140-1154.2002 11807075 (Pubitemid 34113383)
14. Bacterial biofilms: a common cause of persistent infections. Costerton JW, Stewart PS, Greenberg EP, Science 1999 284 1318 1322 10.1126/science.284. 5418.1318 10334980 (Pubitemid 29289651)
15. Ceftazidime, gentamicin, and rifampicin, in combination, kill biofilms of mucoid Pseudomonas aeruginosa. Ghani M, Soothill JS, Can J Microbiol 1997 43 999 1004 10.1139/m97-144 9436304 (Pubitemid 28055431)
16. Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung. Sriramulu DD, Lunsdorf H, Lam JS, Romling U, J Med Microbiol 2005 54 667 676 10.1099/jmm.0.45969-0 15947432 (Pubitemid 40885151)
17. Constituents of mucus and their separation. Creeth JM, Br Med Bull 1978 34 17 24 342044 (Pubitemid 8234011)
18. Mucins, mucus, and sputum. Voynow JA, Rubin BK, Chest 2009 135 505 512 10.1378/chest.08-0412 19201713
19. Mucin-Pseudomonas aeruginosa interactions promote biofilm formation and antibiotic resistance. Landry RM, An D, Hupp JT, Singh PK, Parsek MR, Mol Microbiol 2006 59 142 151 10.1111/j.1365-2958.2005.04941.x 16359324
20. Quantification of biofilm structures by the novel computer program COMSTAT. Heydorn A, Nielsen AT, Hentzer M, Sternberg C, Givskov M, Ersboll BK, Molin S, Microbiology 2000 146 2395 2407 11021916
21. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, Birrer P, Bellon G, Berger J, Weiss T, et al. J Clin Invest 2002 109 317 325 11827991 (Pubitemid 34141805)
22. Anaerobic physiology of Pseudomonas aeruginosa in the cystic fibrosis lung. Schobert M, Jahn D, Int J Med Microbiol 2010 300 549 556 10.1016/j.ijmm.2010.08.007 20951638
23. Regulation of toxA by PtxR in Pseudomonas aeruginosa PA103. Carty NL, Rumbaugh KP, Hamood AN, Can J Microbiol 2003 49 450 464 10.1139/w03-058 14569286 (Pubitemid 37421753)
24. The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. III. Identity of the lethal toxins produced in vitro and in vivo. Liu PV, J Infect Dis 1966 116 481 489 10.1093/infdis/116.4.481 4959184
25. Contribution of quorum sensing to the virulence of Pseudomonas aeruginosa in burn wound infections. Rumbaugh KP, Griswold JA, Iglewski BH, Hamood AN, Infect Immun 1999 67 5854 5862 10531240 (Pubitemid 29508110)
26. Characterization of the type a flagellin gene from Pseudomonas aeruginosa PAK. Totten PA, Lory S, J Bacteriol 1990 172 7188 7199 2123866
27. Analysis of quorum sensing-deficient clinical isolates of Pseudomonas aeruginosa. Schaber JA, Carty NL, McDonald NA, Graham ED, Cheluvappa R, Griswold JA, Hamood AN, J Med Microbiol 2004 53 841 853 10.1099/jmm.0.45617-0 15314190 (Pubitemid 39238389)
28. Rhamnolipid surfactant production affects biofilm architecture in Pseudomonas aeruginosa PAO1. Davey ME, Caiazza NC, O'Toole GA, J Bacteriol 2003 185 1027 1036 10.1128/JB.185.3.1027-1036.2003 12533479 (Pubitemid 36139462)
29. Quorum-sensing regulation of the biofilm matrix genes (pel) of Pseudomonas aeruginosa. Sakuragi Y, Kolter R, J Bacteriol 2007 189 5383 5386 10.1128/JB.00137-07 17496081 (Pubitemid 47076084)
30. The impact of quorum sensing and swarming motility on Pseudomonas aeruginosa biofilm formation is nutritionally conditional. Shrout JD, Chopp DL, Just CL, Hentzer M, Givskov M, Parsek MR, Mol Microbiol 2006 62 1264 1277 10.1111/j.1365-2958.2006.05421.x 17059568 (Pubitemid 44707193)
31. Secreted LasA of Pseudomonas aeruginosa is a staphylolytic protease. Kessler E, Safrin M, Olson JC, Ohman DE, J Biol Chem 1993 268 7503 7508 8463280 (Pubitemid 23105649)
32. 2-Heptyl-4-hydroxyquinoline N-oxide, an antistaphylococcal agent produced by Pseudomonas aeruginosa. Machan ZA, Taylor GW, Pitt TL, Cole PJ, Wilson R, J Antimicrob Chemother 1992 30 615 623 10.1093/jac/30.5.615 1493979 (Pubitemid 23009008)
33. A fatty acid messenger is responsible for inducing dispersion in microbial biofilms. Davies DG, Marques CN, J Bacteriol 2009 191 1393 1403 10.1128/JB.01214-08 19074399
34. Genetic tools for tagging Gram-negative bacteria with mCherry for visualization in vitro and in natural habitats, biofilm and pathogenicity studies. Lagendijk EL, Validov S, Lamers GE, de Weert S, Bloemberg GV, FEMS Microbiol Lett 2010 305 81 90 10.1111/j.1574-6968.2010.01916.x 20180857
35. Diversity of biofilms produced by quorum-sensing-deficient clinical isolates of Pseudomonas aeruginosa. Schaber JA, Hammond A, Carty NL, Williams SC, Colmer-Hamood JA, Burrowes BH, Dhevan V, Griswold JA, Hamood AN, J Med Microbiol 2007 56 738 748 10.1099/jmm.0.47031-0 17510257 (Pubitemid 46911227)
36. MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation. Henke MO, John G, Germann M, Lindemann H, Rubin BK, Am J Respir Crit Care Med 2007 175 816 821 10.1164/rccm.200607-1011OC 17255563 (Pubitemid 46631793)
37. Transcriptional activation of mucin by Pseudomonas aeruginosa lipopolysaccharide in the pathogenesis of cystic fibrosis lung disease. Li JD, Dohrman AF, Gallup M, Miyata S, Gum JR, Kim YS, Nadel JA, Prince A, Basbaum CB, Proc Natl Acad Sci U S A 1997 94 967 972 10.1073/pnas.94.3.967 9023366 (Pubitemid 27074431)
38. Activation of NF-kappaB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells. Li JD, Feng W, Gallup M, Kim JH, Gum J, Kim Y, Basbaum C, Proc Natl Acad Sci U S A 1998 95 5718 5723 10.1073/pnas.95.10.5718 9576950 (Pubitemid 28224162)
39. Reactive oxygen species regulate Pseudomonas aeruginosa lipopolysaccharide-induced MUC5AC mucin expression via PKC-NADPH oxidase-ROS-TGF-alpha signaling pathways in human airway epithelial cells. Yan F, Li W, Jono H, Li Q, Zhang S, Li JD, Shen H, Biochem Biophys Res Commun 2008 366 513 519 10.1016/j.bbrc.2007.11.172 18073139 (Pubitemid 50010533)
40. Serine proteases degrade airway mucins in cystic fibrosis. Henke MO, John G, Rheineck C, Chillappagari S, Naehrlich L, Rubin BK, Infect Immun 2011 79 3438 3444 10.1128/IAI.01252-10 21646446
41. Extracellular DNA required for bacterial biofilm formation. Whitchurch CB, Tolker-Nielsen T, Ragas PC, Mattick JS, Science 2002 295 1487 10.1126/science.295.5559.1487 11859186 (Pubitemid 34173996)
42. A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms. Allesen-Holm M, Barken KB, Yang L, Klausen M, Webb JS, Kjelleberg S, Molin S, Givskov M, Tolker-Nielsen T, Mol Microbiol 2006 59 1114 1128 10.1111/j.1365-2958.2005.05008.x 16430688
43. DNA concentration and length in sputum of patients with cystic fibrosis during inhalation with recombinant human DNase. Brandt T, Breitenstein S, von der Hardt H, Tümmler B, Thorax 1995 50 880 882 10.1136/thx.50.8.880 7570441
44. Iron deficiency leads to inhibition of oxygen transfer and enhanced formation of virulence factors in cultures of Pseudomonas aeruginosa PAO1. Kim EJ, Sabra W, Zeng AP, Microbiology 2003 149 2627 2634 10.1099/mic.0.26276-0 12949186 (Pubitemid 37160736)
45. Regulation of the Pseudomonas aeruginosa toxA, regA and ptxR genes by the iron-starvation sigma factor PvdS under reduced levels of oxygen. Gaines JM, Carty NL, Tiburzi F, Davinic M, Visca P, Colmer-Hamood JA, Hamood AN, Microbiology 2007 153 4219 4233 10.1099/mic.0.2007/011338-0 18048935
46. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg EP, Science 1998 280 295 298 10.1126/science.280.5361.295 9535661 (Pubitemid 28178075)
47. Autoinducer-mediated regulation of rhamnolipid biosurfactant synthesis in Pseudomonas aeruginosa. Ochsner UA, Reiser J, Proc Natl Acad Sci U S A 1995 92 6424 6428 10.1073/pnas.92.14.6424 7604006
48. Regulation of las and rhl quorum sensing in Pseudomonas aeruginosa. Pesci EC, Pearson JP, Seed PC, Iglewski BH, J Bacteriol 1997 179 3127 3132 9150205 (Pubitemid 27202984)
49. Multiple roles of biosurfactants in structural biofilm development by Pseudomonas aeruginosa. Pamp SJ, Tolker-Nielsen T, J Bacteriol 2007 189 2531 2539 10.1128/JB.01515-06 17220224 (Pubitemid 46411367)
50. Rhamnolipids mediate detachment of Pseudomonas aeruginosa from biofilms. Boles BR, Thoendel M, Singh PK, Mol Microbiol 2005 57 1210 1223 10.1111/j.1365-2958.2005.04743.x 16101996 (Pubitemid 41176519)
51. Cloning and characterization of the Pseudomonas aeruginosa lasR gene, a transcriptional activator of elastase expression. Gambello MJ, Iglewski BH, J Bacteriol 1991 173 3000 3009 1902216
52. Species interactions in mixed-community crystalline biofilms on urinary catheters. Macleod SM, Stickler DJ, J Med Microbiol 2007 56 1549 1557 10.1099/jmm.0.47395-0 17965358 (Pubitemid 350175083)
53. Growth and detachment of cell clusters from mature mixed-species biofilms. Stoodley P, Wilson S, Hall-Stoodley L, Boyle JD, Lappin-Scott HM, Costerton JW, Appl Environ Microbiol 2001 67 5608 5613 10.1128/AEM.67.12.5608- 5613.2001 11722913 (Pubitemid 33640996)
54. Pseudomonas aeruginosa extracellular products inhibit staphylococcal growth, and disrupt established biofilms produced by Staphylococcus epidermidis. Qin Z, Yang L, Qu D, Molin S, Tolker-Nielsen T, Microbiology 2009 155 2148 2156 10.1099/mic.0.028001-0 19389780
55. Toxin A-deficient mutants of Pseudomonas aeruginosa PA103: isolation and characterization. Ohman DE, Sadoff JC, Iglewski BH, Infect Immun 1980 28 899 908 6772570 (Pubitemid 10122521)
56. Gentian violet and ferric ammonium citrate disrupt Pseudomonas aeruginosa biofilms. Wang EW, Agostini G, Olomu O, Runco D, Jung JY, Chole RA, Laryngoscope 2008 118 2050 2056 10.1097/MLG.0b013e3181826e24 18849857
57. Cloning and expression of the pilin gene of Pseudomonas aeruginosa PAK in Escherichia coli. Strom MS, Lory S, J Bacteriol 1986 165 367 372 2867989 (Pubitemid 16060501)
58. Chromosomal genetics of Pseudomonas. Holloway BW, Krishnapillai V, Morgan AF, Microbiol Rev 1979 43 73 102 111024 (Pubitemid 9169387)
59. Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of elastase and rhamnolipid biosynthesis genes. Pearson JP, Pesci EC, Iglewski BH, J Bacteriol 1997 179 5756 5767 9294432 (Pubitemid 27398275)
60. Synthesis of multiple exoproducts in Pseudomonas aeruginosa is under the control of RhlR-RhlI, another set of regulators in strain PAO1 with homology to the autoinducer-responsive LuxR-LuxI family. Brint JM, Ohman DE, J Bacteriol 1995 177 7155 7163 8522523
61. Comprehensive transposon mutant library of Pseudomonas aeruginosa. Jacobs MA, Alwood A, Thaipisuttikul I, Spencer D, Haugen E, Ernst S, Will O, Kaul R, Raymond C, Levy R, Chun-Rong L, Guenthner D, Bovee D, Olson MV, Manoil C, Proc Natl Acad Sci U S A 2003 100 14339 14344 10.1073/pnas.2036282100 14617778 (Pubitemid 37499238)
62. Fluorescent reporters for Staphylococcus aureus. Malone CL, Boles BR, Lauderdale KJ, Thoendel M, Kavanaugh JS, Horswill AR, J Microbiol Methods 2009 77 251 260 10.1016/j.mimet.2009.02.011 19264102
63. Transformation of Pseudomonas aeruginosa by electroporation. Smith A, Iglewski BH, Nucleic Acids Res 1989 17 10509 10.1093/nar/17.24.10509 2513561 (Pubitemid 20012219)
64. Serum inhibits P. aeruginosa biofilm formation on plastic surfaces and intravenous catheters. Hammond A, Dertien J, Colmer-Hamood JA, Griswold JA, Hamood AN, J Surg Res 2010 159 735 746 10.1016/j.jss.2008.09.003 19482317
65. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. O'Toole GA, Kolter R, Mol Microbiol 1998 28 449 461 10.1046/j.1365-2958.1998. 00797.x 9632250 (Pubitemid 28218392)